Abstract Cerebrovascular disease resulting in stroke is a serious and preventable complication of sickle cell anaemia (SCA). Children at high risk of preventable stroke can be identified by transcranial Doppler ultrasound (TCD). Current guidelines in the UK recommend annual TCD screening from 3 years, although studies suggest an earlier peak incidence, between 2 and 5 years. A single centre retrospective review was undertaken to identify the prevalence of stroke and success of TCD screening in young children. We report five episodes of stroke in under 3s and outcome of TCD screening in children under 3, compared to over 3. TCD analysis was as successful in the 2-3-year age group as in the 3-4-year group. We therefore propose that all children with SCA should be offered TCD screening from the age of 2 years. Furthermore, infants with high risk features of SCA should undergo a first attempt at TCD screening even earlier.
Introduction
Sickle cell anaemia (SCA) is an inherited condition characterised by haemolysis and vaso-occlusive episodes causing acute pain and organ damage. Cerebrovascular occlusive disease, predominantly affecting the middle cerebral arteries, resulting in stroke is a serious and preventable complication of SCA, most common in homozygotes (HbSS). SCA has been shown to be the most significant risk factor for stroke in the USA childhood population [1] . Eleven percent of strokes occur by the age of 20 years in patients with SCA, with the highest rate of 1 per 100 patient years in those aged 2 to 5 years [2] . Progressive cerebrovascular disease and stroke are largely preventable complications of SCA. The Stroke Prevention Trial in Sickle Cell Anemia (STOP) study demonstrated that early detection of abnormal cerebral blood vessel flow by transcranial Doppler ultrasonography (TCD) and initiation of a blood transfusion programme in those with elevated measurements was successful in reducing the rate of first stroke [3] . This has resulted in the current guidelines in the UK recommending screening of children with SCA by TCD from the age of 3 years [4, 5] . Children with abnormal TCD velocities (greater than 200 cm/s in internal carotid (ICA) or middle cerebral artery (MCA) on two occasions) should commence a blood transfusion programme, to prevent a first stroke [3] .
Other factors may be important in predicting an increased risk of stroke. Miller and colleagues found dactylitis, severe anaemia and leucocytosis in the first 2 years of life predictive of future adverse outcome [6] . Elevated TCD measurements have been correlated with lactate dehydrogenase (LDH) [7] , in addition to low haemoglobin and aspartate transaminase (AST) [8] . Markers of haemolysis, such as LDH and AST, may therefore be useful in stroke prediction. Underlying genetic risk is also recognised with an established association between the tumor necrosis factor (TNF; −308)G/A variant and risk of large vessel stroke. Other genetic variants, such as IL4R 503 S/P and LTC4S (−444) A/C may also predispose to increased risk of large vessel stroke in SCA [9, 10] .
We describe five cases of stroke in children with SCA occurring at less than 3 years of age over a 16-year period. We report our experience of TCD in children aged 2 to 4 years of age and propose current guidance be revised to initiate routine screening from 2 years, with selected screening in younger children with high risk features.
Materials and methods

Case histories
A single centre retrospective review of cases with stroke occurring in children less than 3 years was undertaken. The case notes were reviewed to establish age at presentation, precipitating events, features of high risk disease, stroke distribution, previous TCD results and clinical outcome. The review was conducted as part of an audit into the effectiveness of the TCD programme and, in particular, the success rate of screening in young children.
Transcranial Doppler screening in early childhood
We retrospectively reviewed outcomes in children undergoing TCD screening in age groups 2 to 3 years in comparison with those 3 to 4 years. TCD imaging was performed in a vascular laboratory by trained vascular scientists. Intracerebral blood velocity was measured according to the protocol used in the STOP study [3] using TCD imaging. Previous evaluation of TCD imaging versus TCD scanning had shown that both methods gave the same results when used according to strict established protocols [8] . TCD measurements were first attempted between the ages of 2 and 4 years depending on when the child was seen in clinic. TCD imaging was considered normal when the maximum velocities were less than 170 cm/s in the MCA, distal ICA and at the ICA bifurcation bilaterally. A velocity, in any one of these vessels, of more than 200 cm/s was reported as abnormal. Velocities between 170 and 200 cm/s in any of the MCA or distal ICA and velocities greater than 170 cm/s in anterior cerebral artery (ACA) or posterior cerebral artery were considered conditional results.
Data examined included type of sickle cell disease, age, success and result of TCD. Children in these age groups were identified from our database of SCA children from May 2005.
Results
Case histories
Five cases of stroke in less than 3 years old were identified. All cases were HbSS, characteristics of which are summarised in Table 1 .
Case 1 presented in 1992 at the age of 18 months, with a right hemiparesis. Computed tomography (CT) of his brain, without contrast at this time, was normal. He was commenced on a blood transfusion programme, which was discontinued soon after due to poor compliance. He represented at age 3 years 3 months with a left hemiparesis associated with an aplastic crisis triggered by parvovirus. Again, CT brain failed to demonstrate a causative lesion but a transfusion program was successfully re-initiated. Magnetic resonance imaging (MRI) of his head 4 years after the second event revealed signal alteration consistent with previous ischaemia in the right MCA and right ACA artery territories with an attenuated right ACA evident on angiographic sequences. He has continued on a regular blood transfusion programme for the last 16 years without neurological deterioration or evidence of progression of cerebrovascular disease. Case 3 presented age 19 months, with a febrile illness associated with vomiting. A diagnosis of meningitis was confirmed following lumbar puncture. During the course of the illness, he developed a right-sided hemiplegia, facial palsy and ptosis. CT head revealed evidence of infarction in posteroinfero-occipital lobes and the left frontal lobe, with associated cerebral oedema. This was consistent with the acute vasculitic process. TCD measurements were normal. A programme of regular blood transfusions was commenced. The patient was poorly compliant, further TCD remained normal with no further neurological events and he withdrew from the transfusion programme after 10 months.
Case 4 presented age 17 months following a 5-day febrile illness. He was found to be drowsy with an acute right-sided stroke. MRI head revealed multiple high signal ischaemic lesions in the right MCA territory corresponding to evident right MCA narrowing on angiographic sequences. Despite compliance with regular transfusions, maintaining his HbS below 30%, he has had progressive narrowing of his intracerebral blood vessels. He is now receiving hydroxycarbamide in addition to transfusions and is under consideration for a cerebral revascularisation procedure.
Case 5 presented, at 2 years 11 months, just prior to his first scheduled TCD. He had unprecipitated decreased left hand function. CT and MRI demonstrated a right parietal infarct in the right MCA territory. TCD imaging during this admission revealed bilateral abnormal velocities (214 cm/s right MCA, 250 cm/s left MCA). Following the initiation of a blood transfusion regime, he has regained full function of his hand.
Cases 1, 2 and 5 had leucocytosis and baseline haemoglobin of less than 7 g/dL. There was a history of prior dactylitis in case 3 only. Acute data were not available for case 4. Cases 2-5 all commenced a regular transfusion programme. All five cases were male.
Transcranial Doppler screening in early childhood
We identified 115 children from our database born between June 2001 to December 2005 who were eligible for first TCD between the ages of 2 and 4 years. TCD scans were reviewed over a 2.5-year period (May 2005 to December 2007). Twenty-one of these patients were no longer attending clinic or were referred after the age of four. Four patients had multiple scans and one parent refused TCD. Nine patients under regular review were over 4 years at the time of first TCD, and 24 children had not yet had their first TCD. Thus, 64 TCDs were undertaken within the 2-to 4-year age group and are the basis of our review.
The majority of these children had HbSS (73%), with HbSC accounting for 21.1% and the remaining 8.9% being other compound heterozygotes. The median age at the time of TCD was 3.05 years. Further results are summarised in Table 2 below. There were no significant differences between failure rates (4% versus 10%) in younger compared to older children. There are significantly more children aged 2 to 3 years still awaiting first TCD (15 versus 9). There was one conditional scan in an infant aged 2-3 years compared with four conditional and two abnormal scans in older children. This was not statistically significant. All abnormal scans occurred in children with HbSS.
Discussion
It is well known that unexpected stroke due to cerebrovascular disease with vessel narrowing occurs at a significant frequency in infants with SCA at less than 3 years of age. The Cooperative Study of Sickle Cell Disease demonstrated that the highest risk of stroke was in children aged 2-5 years [2] . It has also been shown that those at risk can be predicted by TCD [11] . Children with high flow velocity in intracranial vessels on TCD (greater than or equal to 170 cm/s) have a stroke rate of 10% to 15% per annum compared with an overall risk in children with SCA of less than 1% per year [11] . Furthermore, this group later demonstrated that prophylactic blood transfusion, maintaining HbS below 30% in those with abnormal TCD velocities (>200 cm/s), is effective in preventing stroke [3] . We identified five episodes of stroke in under 3s over a 16-year period in a single institution. Four of these cases may have been identifiable and preventable. Case 3, however, was considered a secondary complication following meningitis, as TCD measurements were normal at both acute presentation and follow-up. TCD screening was not routinely undertaken during the time period over which cases 1 to 4 presented (1992-1996) .Three of four children with potentially preventable stroke (cases 1, 2 and 5) had features to suggest a higher risk of adverse outcome with leucocytosis and severe anaemia at less than 2 years of age. It may be appropriate to use markers of haemolysis, such as low haemoglobin, raised AST [8] and LDH [7] or features described by Miller and colleagues [6] , to guide earlier intervention and screening for adverse outcome. Studies investigating the use of these markers in initiating TCD screening before 2 years of age to predict future risk of stroke would be valuable. Two of the strokes described above occurred in twin siblings, a few months apart. It has been previously reported that abnormal TCD measurements and stroke are more common in children with SCA, who have a sibling with SCA and either abnormal TCD velocities or prior stroke [12, 13] . Earlier TCD screening should be considered for siblings with SCA if there is a family history of sickle-related cerebrovasculopathy. Recent studies have demonstrated genetic variants associated with increased risk of stroke, most convincingly TNF (−308) G/A [9, 10] . It may be possible to utilise genotyping for this and other potential variants in the future to identify infants at higher risk of stroke and selectively instigate earlier TCD screening.
Following the STOP study [3] , guidance was issued in the USA recommending TCD screening from 2 years of age [14] . In the UK, however, annual TCD screening is recommended in children with SCA from 3 years of age [4, 5] . This may stem from a perception that younger children may be less cooperative and TCD technically difficult. In our experience, TCD can be performed successfully in those less than 3 years. There was no significant difference in success or failure rates of TCD in those aged 2 to 3 years compared with older children, with failure rates being low in both groups.
Given the incidence of stroke in children with SCA peaks between 2 and 5 years and TCD is as successful, 2 years may be a more appropriate age point to recommend for a national screening programme and is the policy we have now adopted in our unit. However, in our series, three children had an unprecipitated stroke under the age of 2 years and would have been missed by any proposed or existing screening programme. Vigilance for features which suggest a high risk of stroke in infants under 2 years should be encouraged. The presence of a family history of SCA-related stroke, prior neurological events, low haemoglobin or high LDH should alert the physician to a possible higher risk of stroke and TCD should be attempted before age 2 years. Sedation may be appropriate to facilitate TCD in such high risk infants, although this may elevate TCD measurements and cause false positive results.
